Directory → Immunotropona funds → Immunosuppressants → Tauredon
This page is translated automatically with a help of Google Translate

Tauredon

See also Lithium aurothiomalate

Roman name

Tauredon

Of drugs

The base product for the treatment of autoimmune diseases. The braking антиген-индуцированн��й lymphocyte stimulation, oppression and monocitarnogo granulozitarnogo phagocytosis, the stabilization of lysosomal membranes, the collagen fibers assumption immunologicaki active sites potentially autoimmunny process. Clinical effect occurs between 9 and 17 weeks, when the total dose of gold ranged from 300 mg to 800 mg.

Pregnancy and lactation

Tauredon contraindicated for the treatment of pregnancy and lactation.

Specific guidance

Tauredon should be imposed only deep injection using disposable syringes.

Storage conditions

B. List in a dry, cool, the dark spot

Shelf life

3 years

The registration

008,456 (Ann.2002)

All products of this group